Jan Kaiserle

Despite the remarkable advancements in medical science and technology that define modern healthcare, a critical component of patient data exchange remains stubbornly anchored in the past, often relying on the same plastic discs once used for music albums. The routine practice of burning

A critical yet often invisible bottleneck within modern hospitals is causing significant delays in patient care, not because of medical error or a lack of clinical staff, but due to a fundamental breakdown in logistics. Rovex Technologies Corporation, a Gainesville-based startup founded by

A groundbreaking initiative from Dalhousie University's School of Health Sciences is simultaneously addressing two of Nova Scotia's most significant challenges by establishing a new Diagnostic Medical Ultrasound Clinic that serves as both a premier training facility for students and a vital

A Regulatory Standoff with High Stakes In a move that sent shockwaves through the biotechnology sector, the U.S. Food and Drug Administration (FDA) has taken the extraordinary step of refusing to conduct a formal review of Moderna's biologics license application for its mRNA-based influenza

The traditional framework of clinical research is undergoing a fundamental and necessary transformation, moving away from a model built for institutional convenience to one that prioritizes the lived experiences and active participation of patients. For decades, the structure of clinical trials

In the sterile, controlled environments of medical laboratories where life-saving diagnoses are made, an invisible threat has long been an accepted part of the daily routine for countless healthcare professionals. This danger comes in the form of hazardous chemicals embedded within the very

Despite boasting some of the world's most impressive cancer survival rates, Australia has long contended with a troubling paradox where these positive outcomes are not shared equally across its population. A new national initiative is set to address this deep-seated disparity, which

With the recent launch of the TrumpRx portal, the White House has waded directly into the complex world of pharmaceutical sales, promising lower prices for Americans. To unpack the real-world implications of this move, we're speaking with James Maitland, a leading analyst whose work has

A significant portion of difficult-to-treat high blood pressure cases stems from a condition known as primary aldosteronism, where the adrenal glands produce excessive amounts of the hormone aldosterone. Identifying the precise source of this overproduction is critical, as it dictates a

With the recent passage of a major government funding bill, the conversation in Washington has shifted from the brink of a shutdown to the substance of the legislation itself. Buried within the appropriations are significant healthcare reforms that promise to reshape key parts of the industry. To